NASDAQ:CBIO
$0.240
(
3.90%
)
Monday, 5th Jun 2023
Catalyst Biosciences Stock Price (Quote)
Range | Low Price | High Price | Comment |
---|---|---|---|
30 days | $0.210 | $0.250 | Monday, 5th Jun 2023 CBIO stock ended at $0.240. This is 3.9% more than the trading day before Friday, 2nd Jun 2023. During the day the stock fluctuated 8.08% from a day low at $0.231 to a day high of $0.250. |
90 days | $0.189 | $0.250 | |
52 weeks | $0.189 | $2.09 |
Historical Catalyst Biosciences prices
Date | Open | High | Low | Close | Volume |
2022-06-06 | $1.26 | $1.40 | $1.13 | $1.17 | 3 602 499 |
2022-06-03 | $1.20 | $1.25 | $1.19 | $1.25 | 700 940 |
2022-06-02 | $1.15 | $1.31 | $1.14 | $1.20 | 2 156 743 |
2022-06-01 | $1.23 | $1.24 | $1.14 | $1.19 | 1 300 445 |
2022-05-31 | $1.20 | $1.33 | $1.15 | $1.24 | 2 278 376 |
2022-05-27 | $1.14 | $1.23 | $1.07 | $1.23 | 4 673 414 |
2022-05-26 | $1.45 | $1.52 | $1.07 | $1.11 | 10 194 944 |
2022-05-25 | $1.23 | $1.52 | $1.20 | $1.43 | 30 696 747 |
2022-05-24 | $1.05 | $1.38 | $1.03 | $1.34 | 49 395 941 |
2022-05-23 | $0.95 | $1.47 | $0.90 | $1.27 | 239 985 920 |
2022-05-20 | $0.420 | $0.420 | $0.371 | $0.380 | 67 878 |
2022-05-19 | $0.365 | $0.403 | $0.365 | $0.380 | 78 876 |
2022-05-18 | $0.390 | $0.409 | $0.370 | $0.370 | 59 968 |
2022-05-17 | $0.397 | $0.419 | $0.371 | $0.400 | 421 123 |
2022-05-16 | $0.362 | $0.420 | $0.362 | $0.399 | 376 756 |
2022-05-13 | $0.376 | $0.385 | $0.357 | $0.360 | 129 781 |
2022-05-12 | $0.366 | $0.400 | $0.350 | $0.365 | 126 691 |
2022-05-11 | $0.365 | $0.400 | $0.365 | $0.366 | 88 642 |
2022-05-10 | $0.445 | $0.460 | $0.362 | $0.366 | 671 467 |
2022-05-09 | $0.479 | $0.479 | $0.435 | $0.435 | 234 502 |
2022-05-06 | $0.460 | $0.492 | $0.460 | $0.491 | 67 533 |
2022-05-05 | $0.490 | $0.509 | $0.460 | $0.473 | 176 909 |
2022-05-04 | $0.485 | $0.492 | $0.476 | $0.492 | 62 922 |
2022-05-03 | $0.478 | $0.492 | $0.472 | $0.475 | 59 586 |
2022-05-02 | $0.483 | $0.492 | $0.463 | $0.472 | 150 269 |
2022-04-29 | $0.510 | $0.520 | $0.460 | $0.479 | 156 709 |
2022-04-28 | $0.500 | $0.520 | $0.472 | $0.490 | 222 969 |
2022-04-27 | $0.547 | $0.550 | $0.505 | $0.520 | 79 446 |
2022-04-26 | $0.560 | $0.598 | $0.540 | $0.540 | 123 326 |
2022-04-25 | $0.561 | $0.599 | $0.550 | $0.557 | 234 420 |
2022-04-22 | $0.523 | $0.650 | $0.505 | $0.578 | 257 079 |
2022-04-21 | $0.520 | $0.540 | $0.510 | $0.520 | 139 100 |
2022-04-20 | $0.540 | $0.540 | $0.500 | $0.520 | 147 600 |
2022-04-19 | $0.520 | $0.550 | $0.520 | $0.530 | 77 500 |
2022-04-18 | $0.550 | $0.570 | $0.520 | $0.520 | 74 300 |
2022-04-14 | $0.565 | $0.571 | $0.543 | $0.554 | 128 439 |
2022-04-13 | $0.600 | $0.600 | $0.560 | $0.566 | 176 542 |
2022-04-12 | $0.580 | $0.620 | $0.574 | $0.583 | 358 909 |
2022-04-11 | $0.603 | $0.636 | $0.572 | $0.588 | 168 348 |
2022-04-08 | $0.679 | $0.679 | $0.613 | $0.613 | 241 042 |
2022-04-07 | $0.630 | $0.670 | $0.620 | $0.660 | 157 300 |
2022-04-06 | $0.660 | $0.660 | $0.620 | $0.640 | 88 700 |
2022-04-05 | $0.670 | $0.670 | $0.630 | $0.640 | 87 000 |
2022-04-04 | $0.690 | $0.690 | $0.650 | $0.670 | 180 800 |
2022-04-01 | $0.689 | $0.690 | $0.660 | $0.660 | 165 180 |
2022-03-31 | $0.645 | $0.689 | $0.645 | $0.660 | 89 817 |
2022-03-30 | $0.660 | $0.670 | $0.645 | $0.650 | 90 045 |
2022-03-29 | $0.690 | $0.690 | $0.650 | $0.650 | 177 800 |
2022-03-28 | $0.690 | $0.690 | $0.660 | $0.690 | 115 100 |
2022-03-25 | $0.700 | $0.710 | $0.680 | $0.690 | 81 100 |
About Catalyst Biosciences
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);... CBIO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.